Loading clinical trials...
Loading clinical trials...
Characterization of Ventricular Tachycardia Ablation in End-stage Heart Failure Patients With Left Ventricular Assist Device
The CHANNELED-Registry is a multicenter retrospective study to (1) systematically assess the mechanism and origin of ventricular tachycardia in patients with end-stage heart failure carrying an left ventricular assist device (LVAD) and (2) to evaluate procedural parameters and outcome of ventricular tachycardia ablation in this special subset of patients.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Start Date
September 25, 2023
Primary Completion Date
January 15, 2024
Completion Date
May 15, 2024
Last Updated
October 3, 2023
50
ESTIMATED participants
Ablation
OTHER
Lead Sponsor
Universitätsklinikum Köln
NCT06743789
NCT07263139
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06378996